From the Community, For the Community

In this special episode, I am joined by two of my long-time friends and collaborators, Professor Jean-François Korobelnik, my Co-chair of the Vision Academy and Professor of Ophthalmology at the University Hospital of Bordeaux, France, and Dr Jane Barratt, my Co-chair of the Barometer Program, and former Secretary General and Global Advisor at the International Federation of Ageing.Tune in as we unpack the statement “From the Community, For the Community,” exploring how collaborations between academia, industry, and non-governmental organizations shape clinical practice and influence policy, with practical advice for listeners keen to get involved in such initiatives, and drive meaningful change.This episode was recorded live at the Joint Vision Academy Steering Committee and Barometer Leadership Coalition Meeting in Rome in February 2025. To learn more about these programs, find your country’s representative, and access the important materials and training resources for clinicians and patients to improve patient-focused care and clinical practice, visit the Vision Academy Program website and nAMD Barometer Program website.If you enjoyed this episode, SUBSCRIBE to “A Chat with Anat” to make sure you never miss an episode! Speaker disclosures:Professor Anat LoewensteinConsultant: 4DMT, Abbvie, Astellas, Aviceda, Bayer, Beyeonics, Boehringer Ingelheim; Eyepoint, NotalVision, Ocular Therapeutix, Oculis, Ocuphire, Opthea, Roche, and Voiant.Professor Jean-François KorobelnikConsultant: AbbVie, Adverum, Apellis, Bayer, Boehringer Ingelheim, Carl Zeiss Meditec, EyePoint, Ocular Therapeutix, Roche, SeaBeLife, and Théa; Member of data safety monitoring board: Alexion, Novo Nordisk, and Opthea.Dr Jane BarrattConsultant: Bayer.August 2025 | PP-PF-OPHT-ALL-0231-1This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.